Matches in SemOpenAlex for { <https://semopenalex.org/work/W3201747807> ?p ?o ?g. }
- W3201747807 endingPage "1072" @default.
- W3201747807 startingPage "1063" @default.
- W3201747807 abstract "Abstract Combretastatin A‐4 (CA4), a tubulin inhibitor, binds to the colchicine site of tubulin, inhibits tubulin polymerization, and leads to the apoptosis of tumor cells. However, the poor hydrophilicity and blood–brain barrier (BBB) penetration ability of CA4 hampers its application in the treatment of glioma. In this study, a novel combretastatin A‐4 derivative (CA4D) was designed and developed, which was further conjugated with glucose via disulfide‐bond‐bridged (CA4D‐SS‐Glu) to enhance the BBB penetration capacity. The obtained CA4D‐SS‐Glu conjugate displayed a suitable water partition coefficient and the superior ability across BBB in vitro and in vivo. In addition, the CA4D‐SS‐Glu exhibited rapid redox‐responsive drug release in the presence of glutathione, enhanced in vitro cytotoxicity, and cell apoptosis. Our data further confirmed that CA4D‐SS‐Glu inhibited proliferation, and restrained migration via affecting microtubule stabilization. Additionally, the conjugate also showed the highest antiproliferative and antitumor action on glioma in vivo as compared to CA4D and CA4. Taken together, the novel CA4D‐SS‐Glu conjugate possess improved physicochemical property and BBB penetration ability, reduction triggered release of CA4D, and efficient antiproliferative activity. These results provided a novel and effective entry to the treatment of glioma." @default.
- W3201747807 created "2021-10-11" @default.
- W3201747807 creator A5008715396 @default.
- W3201747807 creator A5025014865 @default.
- W3201747807 creator A5033532580 @default.
- W3201747807 creator A5049692788 @default.
- W3201747807 creator A5054301812 @default.
- W3201747807 creator A5072955324 @default.
- W3201747807 creator A5076799863 @default.
- W3201747807 creator A5082226210 @default.
- W3201747807 date "2021-09-29" @default.
- W3201747807 modified "2023-10-18" @default.
- W3201747807 title "Redox‐responsive glycosylated combretastatin A‐4 derivative as novel tubulin polymerization inhibitor for glioma and drug delivery" @default.
- W3201747807 cites W1994297035 @default.
- W3201747807 cites W2076086273 @default.
- W3201747807 cites W2076790650 @default.
- W3201747807 cites W2124016864 @default.
- W3201747807 cites W2152021629 @default.
- W3201747807 cites W2749402434 @default.
- W3201747807 cites W2765207564 @default.
- W3201747807 cites W2766719463 @default.
- W3201747807 cites W2775426308 @default.
- W3201747807 cites W2799378760 @default.
- W3201747807 cites W2900379139 @default.
- W3201747807 cites W2901055078 @default.
- W3201747807 cites W2906332712 @default.
- W3201747807 cites W2908469984 @default.
- W3201747807 cites W2947197516 @default.
- W3201747807 cites W2950420084 @default.
- W3201747807 cites W2969841431 @default.
- W3201747807 cites W2972946105 @default.
- W3201747807 cites W2975725386 @default.
- W3201747807 cites W2981252772 @default.
- W3201747807 cites W2988945636 @default.
- W3201747807 cites W2990473897 @default.
- W3201747807 cites W2992566202 @default.
- W3201747807 cites W3003244617 @default.
- W3201747807 cites W3096705092 @default.
- W3201747807 cites W3100679715 @default.
- W3201747807 cites W3196744988 @default.
- W3201747807 cites W4242076823 @default.
- W3201747807 doi "https://doi.org/10.1002/ddr.21889" @default.
- W3201747807 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34585392" @default.
- W3201747807 hasPublicationYear "2021" @default.
- W3201747807 type Work @default.
- W3201747807 sameAs 3201747807 @default.
- W3201747807 citedByCount "6" @default.
- W3201747807 countsByYear W32017478072021 @default.
- W3201747807 countsByYear W32017478072022 @default.
- W3201747807 countsByYear W32017478072023 @default.
- W3201747807 crossrefType "journal-article" @default.
- W3201747807 hasAuthorship W3201747807A5008715396 @default.
- W3201747807 hasAuthorship W3201747807A5025014865 @default.
- W3201747807 hasAuthorship W3201747807A5033532580 @default.
- W3201747807 hasAuthorship W3201747807A5049692788 @default.
- W3201747807 hasAuthorship W3201747807A5054301812 @default.
- W3201747807 hasAuthorship W3201747807A5072955324 @default.
- W3201747807 hasAuthorship W3201747807A5076799863 @default.
- W3201747807 hasAuthorship W3201747807A5082226210 @default.
- W3201747807 hasConcept C109316439 @default.
- W3201747807 hasConcept C12554922 @default.
- W3201747807 hasConcept C134306372 @default.
- W3201747807 hasConcept C150903083 @default.
- W3201747807 hasConcept C181199279 @default.
- W3201747807 hasConcept C185592680 @default.
- W3201747807 hasConcept C190283241 @default.
- W3201747807 hasConcept C197336794 @default.
- W3201747807 hasConcept C202751555 @default.
- W3201747807 hasConcept C20418707 @default.
- W3201747807 hasConcept C207001950 @default.
- W3201747807 hasConcept C2776636253 @default.
- W3201747807 hasConcept C2778227246 @default.
- W3201747807 hasConcept C2778275628 @default.
- W3201747807 hasConcept C33923547 @default.
- W3201747807 hasConcept C502942594 @default.
- W3201747807 hasConcept C538909803 @default.
- W3201747807 hasConcept C54355233 @default.
- W3201747807 hasConcept C55493867 @default.
- W3201747807 hasConcept C71240020 @default.
- W3201747807 hasConcept C84425145 @default.
- W3201747807 hasConcept C86803240 @default.
- W3201747807 hasConcept C95444343 @default.
- W3201747807 hasConcept C98274493 @default.
- W3201747807 hasConceptScore W3201747807C109316439 @default.
- W3201747807 hasConceptScore W3201747807C12554922 @default.
- W3201747807 hasConceptScore W3201747807C134306372 @default.
- W3201747807 hasConceptScore W3201747807C150903083 @default.
- W3201747807 hasConceptScore W3201747807C181199279 @default.
- W3201747807 hasConceptScore W3201747807C185592680 @default.
- W3201747807 hasConceptScore W3201747807C190283241 @default.
- W3201747807 hasConceptScore W3201747807C197336794 @default.
- W3201747807 hasConceptScore W3201747807C202751555 @default.
- W3201747807 hasConceptScore W3201747807C20418707 @default.
- W3201747807 hasConceptScore W3201747807C207001950 @default.
- W3201747807 hasConceptScore W3201747807C2776636253 @default.
- W3201747807 hasConceptScore W3201747807C2778227246 @default.
- W3201747807 hasConceptScore W3201747807C2778275628 @default.
- W3201747807 hasConceptScore W3201747807C33923547 @default.